{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:07:23Z","timestamp":1757614043547,"version":"3.44.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pulmonary hypertension (PH) is a life-threatening disease. However, acidosis could be used to predict the prognosis of critically ill patients. Consequently, this study was to identify the link between acidosis and in-hospital death of PH patients based on the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Eligible subjects from the MIMIC-IV database were selected for this analysis (2008\u20132019), after which differences in variables between the survival statuses of PH patients were evaluated. Subsequently, employing three weighted multiple logistic regression models to investigate the link between acidosis and PH. Further, risk stratification analysis were applied to explore the relationships between acidosis as well as other covariates and PH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Total 2,530 PH patients (247 dead and 2,283 live or 157 acidosis and 2,373 non-acidosis) were included in the analysis. Next, the result indicated highly significant differences between the dead and live groups in factors such as acidosis and sepsis (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.0001). It also showed highly significant differences between the acidosis and non-acidosis groups in factors such as creatinine and sepsis (<jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.0001). Subsequently, a consistent significant association was found between acidosis and PH, there into, Model 1 displayed an odds ratio (OR) of 5.53 (95% confidence interval (CI): 3.83\u20137.92, <jats:italic>p<\/jats:italic>\u202f=\u202f2.71\u202f\u00d7\u202f10<jats:sup>\u221220<\/jats:sup>), Model 2 showed an OR of 5.56 (95% CI: 3.83\u20138.00, <jats:italic>p<\/jats:italic>\u202f=\u202f6.33\u202f\u00d7\u202f10<jats:sup>\u221220<\/jats:sup>), Model 3 reported an OR of 2.19 (95% CI: 1.36\u20133.51, <jats:italic>p<\/jats:italic>\u202f=\u202f1\u202f\u00d7\u202f10<jats:sup>\u22123<\/jats:sup>), indicating that the impact of acidosis on PH was not significantly affected by other covariates. Notably, risk stratification further revealed acidosis as a risk factor for PH was stable across populations (OR &amp;gt; 1, <jats:italic>p<\/jats:italic>\u202f&amp;lt;\u202f0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study identified acidosis was a risk factor for PH, highlighting the importance of monitoring in PH patients at risk for acidosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1654432","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T04:14:31Z","timestamp":1757045671000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Acidosis and in-hospital mortality in patients with pulmonary hypertension: a retrospective cohort study based on the MIMIC-IV database"],"prefix":"10.3389","volume":"12","author":[{"given":"Yuheng","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiancheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"ITC49","DOI":"10.7326\/AITC202104200","article-title":"Pulmonary hypertension","volume":"174","author":"Poch","year":"2021","journal-title":"Ann Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/jamacardio.2022.0011","article-title":"Finding pulmonary arterial hypertension-switching to offense to mitigate disease burden","volume":"7","author":"Maron","year":"2022","journal-title":"JAMA Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1164\/rccm.202212-2342CI","article-title":"Progress in the treatment of pulmonary hypertension associated with interstitial lung disease","volume":"208","author":"Nathan","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1007\/s12325-024-02964-0","article-title":"Macitentan and tadalafil combination therapy in incident and prevalent pulmonary arterial hypertension: real-world evidence from the OPUS\/OrPHeUS studies","volume":"41","author":"Chin","year":"2024","journal-title":"Adv Ther"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1439402","DOI":"10.3389\/fcvm.2024.1439402","article-title":"Chronic thromboembolic pulmonary hypertension: the diagnostic assessment","volume":"11","author":"Simeone","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.emc.2023.06.008","article-title":"Metabolic acid-base disorders","volume":"41","author":"Lentz","year":"2023","journal-title":"Emerg Med Clin North Am"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/MCC.0000000000001219","article-title":"Cardiac arrest and microcirculatory dysfunction: a narrative review","volume":"30","author":"Kravitz","year":"2024","journal-title":"Curr Opin Crit Care"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000503775","article-title":"Microcirculation: physiology, pathophysiology, and clinical application","volume":"49","author":"Guven","year":"2020","journal-title":"Blood Purif"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13075-024-03338-1","article-title":"The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC\/ERS guidelines","volume":"26","author":"Li","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S2213-2600(23)00259-X","article-title":"Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management","volume":"11","author":"Olsson","year":"2023","journal-title":"Lancet Respir Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci Data"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1408372","DOI":"10.3389\/fnut.2024.1408372","article-title":"A novel nutritional inflammation index for predicting mortality in acute ischemic stroke patients: insights into advanced lung cancer inflammation index from the medical information Mart for intensive care-IV database","volume":"11","author":"Huang","year":"2024","journal-title":"Front Nutr"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"tkae016","DOI":"10.1093\/burnst\/tkae016","article-title":"Serial platelet count as a dynamic prediction marker of hospital mortality among septic patients","volume":"12","author":"Ye","year":"2024","journal-title":"Burns Trauma"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1002\/sim.1879","article-title":"Regression analysis of multiple source and multiple informant data from complex survey samples","volume":"23","author":"Horton","year":"2004","journal-title":"Stat Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"11340","DOI":"10.1038\/s41598-022-15609-5","article-title":"Applying logistic LASSO regression for the diagnosis of atypical Crohn's disease","volume":"12","author":"Li","year":"2022","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e15476","DOI":"10.7717\/peerj.15476","article-title":"Ferroptosis-associated gene CISD2 suppresses colon cancer development by regulating tumor immune microenvironment","volume":"11","author":"Xu","year":"2023","journal-title":"PeerJ"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"724179","DOI":"10.3389\/fcvm.2021.724179","article-title":"Novel prognostic predictor for primary pulmonary hypertension: focus on blood urea nitrogen","volume":"8","author":"Hu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-023-00486-7","article-title":"Pulmonary hypertension","volume":"10","author":"Mocumbi","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.adj9696","article-title":"Light-gated channelrhodopsin sparks proton-induced calcium release in guard cells","volume":"382","author":"Huang","year":"2023","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"122348","DOI":"10.1016\/j.carbpol.2024.122348","article-title":"Multifunctional pH-responsive hydrogel dressings based on carboxymethyl chitosan: synthesis, characterization fostering the wound healing","volume":"341","author":"Xiong","year":"2024","journal-title":"Carbohydr Polym"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1093\/eurheartj\/ehad672","article-title":"Confirmation of survival prediction based on 2022 ESC\/ERS pulmonary hypertension guidelines new haemodynamic thresholds","volume":"44","author":"Gali\u00e8","year":"2023","journal-title":"Eur Heart J"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.amjms.2021.12.009","article-title":"Impact of pulmonary arterial hypertension on systemic inflammation, cardiac injury and hemodynamics in sepsis: a retrospective study from MIMIC-III","volume":"363","author":"He","year":"2022","journal-title":"Am J Med Sci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"R169","DOI":"10.1186\/cc9264","article-title":"Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review","volume":"14","author":"Price","year":"2010","journal-title":"Crit Care"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1801900","DOI":"10.1183\/13993003.01900-2018","article-title":"Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update","volume":"53","author":"Vonk Noordegraaf","year":"2019","journal-title":"Eur Respir J"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3238\/arztebl.m2023.0222","article-title":"The early detection of pulmonary hypertension","volume":"120","author":"Ley","year":"2023","journal-title":"Dtsch Arztebl Int"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1153573","DOI":"10.3389\/fimmu.2023.1153573","article-title":"Identification of ACKR4 as an immune checkpoint in pulmonary arterial hypertension","volume":"14","author":"Jiang","year":"2023","journal-title":"Front Immunol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.2147\/COPD.S418478","article-title":"Clinical diagnostic value of serum GABA, NE, ET-1, and VEGF in chronic obstructive pulmonary disease with pulmonary hypertension","volume":"18","author":"Yan","year":"2023","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S2213-2600(20)30317-9","article-title":"Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study","volume":"8","author":"Maron","year":"2020","journal-title":"Lancet Respir Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"702.e7","DOI":"10.1016\/j.amjmed.2017.12.046","article-title":"Diabetes mellitus associates with increased right ventricular afterload and remodeling in pulmonary arterial hypertension","volume":"131","author":"Whitaker","year":"2018","journal-title":"Am J Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/ehf2.13752","article-title":"Prognostic significance of insulin resistance in pulmonary hypertension","volume":"9","author":"Zare","year":"2022","journal-title":"ESC Heart Fail"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1210\/endrev\/bnad030","article-title":"Protective factors and the pathogenesis of complications in diabetes","volume":"45","author":"Yu","year":"2024","journal-title":"Endocr Rev"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ajog.2022.05.014","article-title":"Optimizing the management of acute,prolonged decelerations and fetal bradycardia based on the understanding of fetal pathophysiology","volume":"228","author":"Chandraharan","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00011-023-01845-6","article-title":"Inflammation in heart failure: pathophysiology and therapeutic strategies","volume":"73","author":"Boulet","year":"2024","journal-title":"Inflamm Res"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"959209","DOI":"10.3389\/fimmu.2022.959209","article-title":"Pulmonary hypertension: linking inflammation and pulmonary arterial stiffening","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"794549","DOI":"10.3389\/fcvm.2021.794549","article-title":"Circulating interleukin-7 in human pulmonary arterial hypertension","volume":"8","author":"Diekmann","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chest.2022.02.041","article-title":"BMI and treatment response in patients with pulmonary arterial hypertension: a meta-analysis","volume":"162","author":"McCarthy","year":"2022","journal-title":"Chest"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.chest.2015.11.008","article-title":"Effect of age on phenotype and outcomes in pulmonary arterial hypertension trials","volume":"149","author":"Rose","year":"2016","journal-title":"Chest"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1207474","DOI":"10.3389\/fmed.2023.1207474","article-title":"Hepatorenal dysfunction in patients with chronic thromboembolic pulmonary hypertension","volume":"10","author":"Yogeswaran","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"122472","DOI":"10.1016\/j.lfs.2024.122472","article-title":"Calcium sensing receptor: a promising therapeutic target in pulmonary hypertension","volume":"340","author":"Zhang","year":"2024","journal-title":"Life Sci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e14084","DOI":"10.1111\/apha.14084","article-title":"Calcineurin inhibition, cardiovascular consequences, vascular resistance, and potential responses","volume":"240","author":"Luft","year":"2024","journal-title":"Acta Physiol (Oxford)"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1654432\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T04:14:31Z","timestamp":1757045671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1654432\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":41,"alternative-id":["10.3389\/fmed.2025.1654432"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1654432","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"article-number":"1654432"}}